By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MediciNova, Inc. 

4350 La Jolla Village Drive, Suite 950

San Diego  California  92122  U.S.A.
Phone: 858-373-1500 Fax: 858-373-7000



Company News
MediciNova, Inc. To Present Data On MN-001 For The Treatment Of NASH (Nonalcoholic Steatohepatitis) During The JDDW 2014 (Japan Digestive Disease Week 2014) 7/8/2014 6:16:41 AM
MediciNova, Inc. Announces Positive Results In Study Of MN-001 In Mouse Model Of Pulmonary Fibrosis 6/12/2014 7:57:10 AM
MediciNova, Inc. Announces Management Appointment 4/9/2014 8:51:00 AM
MediciNova, Inc. Announces Positive Results In NASH Mouse Model With MN-001 And Prepares To Initiate Phase 2 Trial In The U.S. 1/14/2014 9:09:38 AM
MediciNova, Inc. Receives New Patent Covering MN-221 In Irritable Bowel Syndrome 11/12/2013 12:45:02 PM
MediciNova, Inc. Reports Third Quarter 2013 Results 11/8/2013 9:10:11 AM
MediciNova, Inc. Appoints Geoffrey O'Brien as Vice President 10/17/2013 9:35:31 AM
MediciNova, Inc. Appoints Yutaka Kobayashi to Its Board of Directors 10/17/2013 9:28:06 AM
MediciNova, Inc. Receives Notice of Allowance for New Patent Covering MN-029 (denibulin) di-hydrochloride 10/7/2013 9:46:10 AM
National Institute on Alcohol Abuse and Alcoholism Funds New University of California, Los Angeles (UCLA) Clinical Trial of MediciNova, Inc.'s MN-166 in Treating Alcoholism 8/26/2013 9:46:26 AM